RENUKA TANK: Open Payments
NPI 1063430627 · BAYVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$751 in 34 payments from 11 companies in 2025. Trend: 2023 $150 · 2024 $298 · 2025 $751
Food & beverage: $751
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 11 | $199 |
| Davol Inc. | 1 | $150 |
| Janssen Pharmaceuticals, Inc | 5 | $108 |
| E.R. Squibb & Sons, L.L.C. | 5 | $82 |
| Alkermes, Inc. | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| ABBVIE INC. | 1 | $22 |
| Lundbeck LLC | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
Products named: INGREZZA, Phasix Mesh, ARISTADA, COBENFY, INVEGA SUSTENNA, REXULTI, SPRAVATO, Auvelity.
Industry payments across NJ — which companies pay providers there.
